Tracking Quality in Drug Manufacturing: FDA reviews guidance status

被引：0

作者：

机构：

来源：

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Chemists, chemistry, and the FDA: Building quality into drug manufacturing
Cormier, Elizabeth Pollina
[J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[2] FDA reviews drug safely
不详
[J]. CHEMISTRY WORLD, 2007, 4 (09): : 20 - 20
[3] FDA reviews drug monitoring system
不详
[J]. CHEMICAL & ENGINEERING NEWS, 2004, 82 (46) : 28 - 28
[4] Can FDA reform drug reviews?
Bunk, S
[J]. SCIENTIST, 1998, 12 (06): : 1 - +
[5] FDA Guidance and New Drug Approvals
Walker, Scot
[J]. HOSPITAL PHARMACY, 2018, 53 (06) : 360 - 362
[6] FDA Gives Drug Codevelopment Guidance
不详
[J]. CANCER DISCOVERY, 2013, 3 (10) : 1087 - +
[7] FDA AD Drug Development Guidance
不详
[J]. JOURNAL OF NUCLEAR MEDICINE, 2013, 54 (04) : 16N - 16N
[8] Posting FDA new drug application reviews
Turner, Erick H.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (08): : 863 - 864
[9] FDA Guidance on Drug Development for Early AD
不详
[J]. JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (04) : 14N - 14N
[10] FDA issues draft drug advertising guidance
不详
[J]. JOURNAL OF THE AMERICAN VETERINARY MEDICAL ASSOCIATION, 1997, 211 (07): : 818 - 818